Carol Webb

CIK: 0001671111

Transaction Breakdown

Open Market Buys (P)0 (0.0%)

High conviction signal

Open Market Sales (S)0 (0.0%)

Position reduction

Option Exercises (M)0 (0.0%)

Derivative conversions

Awards (A)3 (100.0%)

Compensation grants

Other (G, F, J, C, D, …)0 (0.0%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (2)

CTOR

CITIUS ONCOLOGY, INC.

Director

CTXR

Citius Pharmaceuticals, Inc.

Director

Discretionary Trading P&L

Holdings

Transaction History (3 total)

CTOR
CITIUS ONCOLOGY, INC.
Sep 19, 2025
Award(A)
Direct
300K shares-
CTOR
CITIUS ONCOLOGY, INC.
Dec 12, 2024
Award(A)
Stock Option (Right to Buy)
Direct
125K shares-
CTXR
Citius Pharmaceuticals, Inc.
Nov 7, 2024
Award(A)
Stock Option (Right to Purchase Common Stock)
Direct
125K shares-

		Type	Shares	Price		Ownership
Sep 19, 2025	CTOR CITIUS ONCOLOGY, INC.	Award(A)	300,000	-	-	Direct
Dec 12, 2024	CTOR CITIUS ONCOLOGY, INC.	Award(A) Stock Option (Right to Buy)	125,000	-	-	Direct
Nov 7, 2024	CTXR Citius Pharmaceuticals, Inc.	Award(A) Stock Option (Right to Purchase Common Stock)	125,000	-	-	Direct

1-3 of 3 transactions

About Webb Carol

Webb Carol (SEC CIK 0001671111) files insider reports with the SEC as Director of CITIUS ONCOLOGY, INC. (CTOR) and Director of Citius Pharmaceuticals, Inc. (CTXR).

Signal8 holds 5 ownership filings by Webb Carol, all Form 4s, filed between Nov 12, 2024 and Dec 22, 2025. Those filings report 3 transactions, from Nov 7, 2024 to Sep 19, 2025. Signal8's Form 4 history starts in Sep 2024.

The business address on Webb Carol's filings is in CRANFORD, NJ.

Recent filings by Webb Carol

Sep 19, 2025: Grant or award of CTOR shares (Form 4, code A).
Dec 12, 2024: Grant or award of CTOR derivative securities (Form 4, code A).
Nov 7, 2024: Grant or award of CTXR derivative securities (Form 4, code A).

Other insiders filing for CITIUS ONCOLOGY, INC. (CTOR)

Peri Jonathan, Director
HOLUBIAK MYRON Z, Secretary
Czuczman Myron, Chief Medical Officer
Bartushak Jaime, Chief Financial Officer
Mazur Leonard L, Chief Executive Officer
Smith Robert Joseph, Director

How to read Form 4 transaction codes